106
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical Significance of Plasma and Serum Vascular Endothelial Growth Factor in Asthma

, M.D., , Ph.D., , M.D., , M.D., , M.D., , M.D. & , M.D. show all
Pages 735-739 | Published online: 02 Jul 2009

References

  • Bousquet J, Jeffery P K, Busse W W, Johnson M, Vignola A M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720–1745
  • Lee K S, Kim S R, Park H S, Jin G Y, Lee Y C. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing VEGF expression. J Allergy Clin Immunol 2004; 114: 1093–1099
  • Lee Y C, Kwak Y G, Song C H. Contribution of vascular endothelial growth factor to airway hyper-responsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 2002; 168: 3595–3600
  • Vrugt B, Wilson S, Bron A, Holgate S T, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 2000; 15: 1014–1021
  • Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001; 56: 902–906
  • Li X, Wilson J W. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156: 229–233
  • Lee Y C, Lee H K. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 2001; 107: 1106
  • Orsida B E, Ward C, Li X, Bish R, Wilson J W, Thien F, Walters E H. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001; 164: 117–121
  • Hogg J C. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999; 54: 283
  • Hoshino M, Nakamura Y, Hamid Q A. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001; 107: 1034–1038
  • Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107: 295–301
  • Charan N B, Baile E M, Pare P D. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997; 10: 1173–1180
  • Van d e, Graaf E A, Out T A, Roos C M, Jansen H M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991; 143: 362–368
  • Dvorak H F, Brown L F, Detmar M, Dvorak A M. Vascular permeability factor /vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–1039
  • Lee C G, Link H, Baluk P, Homer R J, Chapoval S, Bhandari V, Kang M J, Cohn L, Kim Y K, McDonald D M, Elias J A. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004; 10: 1095–1103
  • Lee K S, Min K H, Kim S R, Park S J, Park H S, Jin G Y, Lee Y C. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. Am J Respir Crit Care Med 2006; 174: 161–170
  • Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Tominaga T. Concentrations of vascular endothelial growth factor in sera of normal controls and cancer patients. Clin Cancer Res 1996; 2: 821–826
  • Salven P, Ruotsalainen T, Mattson K, Joensuu H. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 1998; 79: 144–146
  • Fujisaki K, Mitsuyama K, Toyonaga A, Matsuo K, Tanikawa K. Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol 1998; 93: 249–252
  • Feldman A L, Tamarkin L, Paciotti G F, Simpson B W, Linehan W M, Yang J C, Fogler W E, Turner E M, Alexander H R, Jr, Libutti S K. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res 2000; 6: 4628–4634
  • Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, Sakahara H, Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum. Br J Cancer 1997; 76: 1221–1227
  • Poon R T, Ng I O, Lau C, Zhu L X, Yu W C, Lo C M, Fan S T, Wong J. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 2001; 233: 227–235
  • Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett 2000; 153: 7–12
  • Hyodo I, Doi T, Endo H, Hosokawa Y, Nishikawa Y, Tanimizu M, Jinno K, Kotani Y. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer 1998; 34: 2041–2045
  • Tamura M, Ohta Y, Kajita T, Kimura K, Go T, Oda M, Nakamura H, Watanabe G. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Oncol Rep 2001; 8: 1097–1102
  • Davies M M, Jonas S K, Kaur S, Allen-Mersh T G. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume. Br J Cancer 2000; 82: 1004–1008
  • Banks R E, Forbes M A, Kinsey S E, Stanley A, Ingham E, Walters C, Selby P J. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77: 956–964
  • George M L, Eccles S A, Tutton M G, Abulafi A M, Swift R I. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?. Clin Cancer Res 2000; 6: 3147–3152
  • American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
  • Corbridge T C, Hall J B. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995; 151: 1296–1316
  • Thurston G, Rudge J S, Ioffe E, Zhou H, Ross L, Croll S D, Glazer N, Holash J, McDonald D M, Yancopoulos G D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460–463
  • Horiuchi H, Weller P F. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997; 17: 70–77
  • Taichman N S, Young S, Cruchley A T, Taylor P, Paleolog E. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 1997; 62: 397–400
  • Persson C G. Epithelial cells: barrier functions and shedding restitution mechanisms. Am J Respir Crit Care Med 1996; 153: 9S–10S
  • Barnes P J. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332: 868–875
  • Criscuolo G R. The genesis of peritumoral vasogenic brain edema and tumor cysts; a hypothetic role for tumor-derived vascular permeability factor. Yale J Biol Med 1993; 66: 277–314
  • Ohta M, Konno H, Tanaka T, Baba M, Kamiya K, Syouji T, Kondoh K, Watanabe M, Terada H, Nakamura S. The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett 2003; 192: 215–225
  • Verheul H M, Hoekman K, Luykx-de Bakker S, Eekman C A, Folman C C, Broxterman H J, Pinedo H M. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997; 3: 2187–2190
  • Vermeulen P B, Salven P, Benoy I, Gasparini G, Dirix L Y. Blood platelets and serum VEGF in cancer patients. Br J Cancer 1999; 79: 370–373
  • Gunsilius E, Tschmelitsch J, Petzer A L. Correspondence re: M.L. George [correction of H.L. George] et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?. Clin Cancer Res 2000; 6: 3147–3152, Clin Cancer Res, 2001, 7, 443–444
  • Gunsilius E, Petzer A, Stockhammer G, Nussbaumer W, Schumacher P, Clausen J, Gastl G. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology 2000; 58: 169–174

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.